Melitracen Completed Phase 4 Trials for Emotional Disorders / Neurological Disorders Treatment

IndicationsStatusPurposePhase
CompletedTreatment4
clinicaltrials.gov IdentifierTitleDrugs
NCT04970667Flupentixol and Melitracen Tablets in the Treatment of Emotional Disorder